ArticleCanadian journal of veterinary research = Revue canadienne de recherche veterinaire2025
The role of HbA1c in identifying dogs at high risk for diabetes despite normal blood glucose levels.
Article in Canadian journal of veterinary research = Revue canadienne de recherche veterinaire, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The objective of this study was to confirm the clinical utility of hemoglobin A1c (HbA1c) in identifying dogs at a high risk for diabetes. In this cross-sectional study, all the dogs were categorized into a control group and 3 experimental groups (overweight, elderly, and dogs with diseases that can contribute to diabetes). The control group included young and healthy dogs that visited veterinary clinics mainly for health checkups or neutering. The HbA1c concentration of all the dogs was estimated and compared between the control group and the experimental groups. The HbA1c level was significantly higher in the experimental groups than in the control group. In addition, a significant correlation was observed between the HbA1c concentration and all experimental variables. The HbA1c concentration was higher in the overweight group [mean, median: 3.94, 3.9; range (R): 3.5 to 4.3%], the elderly group [mean, median: 3.94, 3.9 (R: 3.5 to 4.3%)], and the disease group [mean, median: 3.99, 4.0 (R: 3.5 to 4.9%)] than in the control group [mean, median: 3.52, 3.6 (R: 2.9 to 3.8%)]. According to the results of this study, HbA1c can be used to evaluate high-risk groups for diabetes in the veterinary field, as in human medicine.
Indexed as
Identifiers
41070219PMC12507055What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.